November 22, 2022, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) trading session started at the price of $14.90, that was 1.76% jump from the session before. During the day, the shares moved up to $15.12 and dropped to $14.62 before settling in for the closing price of $14.78. A 52-week range for ACAD has been $12.24 – $28.06.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
During the last 5-year period, the sales growth of Healthcare Sector giant was 94.60%. When this article was written, the company’s average yearly earnings per share was at 41.60%. With a float of $161.71 million, this company’s outstanding shares have now reached $161.85 million.
Let’s determine the extent of company efficiency that accounts for 510 employees. In terms of profitability, gross margin is +97.53, operating margin of -35.20, and the pretax margin is -34.60.
ACADIA Pharmaceuticals Inc. (ACAD) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ACADIA Pharmaceuticals Inc. stocks. The insider ownership of ACADIA Pharmaceuticals Inc. is 0.10%, while institutional ownership is 94.90%. The most recent insider transaction that took place on Nov 21, was worth 27,834. In this transaction President of this company sold 1,847 shares at a rate of $15.07, taking the stock ownership to the 61,234 shares. Before that another transaction happened on Oct 15, when Company’s President sold 1,326 for $15.81, making the entire transaction worth $20,964. This insider now owns 56,831 shares in total.
ACADIA Pharmaceuticals Inc. (ACAD) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/29/2022, it has been observed that the corporation posted -$0.21 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.25) by $0.04. This company achieved a net margin of -34.67 while generating a return on equity of -28.75. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.00% during the next five years compared to 14.90% growth over the previous five years of trading.
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Trading Performance Indicators
You can see what ACADIA Pharmaceuticals Inc. (ACAD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.78 in one year’s time.
Technical Analysis of ACADIA Pharmaceuticals Inc. (ACAD)
Looking closely at ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), its last 5-days average volume was 0.79 million, which is a drop from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 19.76%. Additionally, its Average True Range was 0.69.
During the past 100 days, ACADIA Pharmaceuticals Inc.’s (ACAD) raw stochastic average was set at 25.94%, which indicates a significant decrease from 45.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.01% in the past 14 days, which was higher than the 51.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.21, while its 200-day Moving Average is $18.60. However, in the short run, ACADIA Pharmaceuticals Inc.’s stock first resistance to watch stands at $15.23. Second resistance stands at $15.43. The third major resistance level sits at $15.73. If the price goes on to break the first support level at $14.73, it is likely to go to the next support level at $14.43. Should the price break the second support level, the third support level stands at $14.23.
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Key Stats
There are 161,931K outstanding shares of the company, which has a market capitalization of 2.41 billion. As of now, sales total 484,150 K while income totals -167,870 K. Its latest quarter income was 130,710 K while its last quarter net income were -27,180 K.